20 results
PRE 14A
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Preliminary proxy
4:03pm
an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. In considering
8-K/A
EX-10.3
kxmif zf04rkpzyxogmk
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
DEF 14A
jzm526 bhrhbsw3
29 Apr 21
Definitive proxy
5:03pm
10-K
1jh4l0qvctc63es1
3 Mar 21
Annual report
9:00am
10-Q
EX-10.7
myi rsromh78osnab
12 Nov 20
Quarterly report
4:27pm
10-Q
tsq0n11 kcnf
12 Nov 20
Quarterly report
4:27pm
424B4
3ujn1ve8fpwc11s 32j
25 Sep 20
Prospectus supplement with pricing info
12:00am
S-1/A
qxntx2te
8 Sep 20
IPO registration (amended)
4:43pm
S-1
xg9jz96439 9t
2 Sep 20
IPO registration
5:02pm
DRS
9af 3sbjz
3 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next